In Vitro Evaluation of In Silico Screening Approaches in Search for Selective ACE2 Binding Chemical Probes

被引：1

作者：

Rayevsky, Alexey, V ^{[1
,2
]}

Poturai, Andrii S. ^{[1
]}

Kravets, Iryna O. ^{[1
,3
]}

Pashenko, Alexander E. ^{[1
,4
,5
]}

Borisova, Tatiana A. ^{[6
]}

Tolstanova, Ganna M. ^{[4
]}

Volochnyuk, Dmitriy M. ^{[1
,3
,4
]}

Borysko, Petro O. ^{[1
]}

Vadzyuk, Olga B. ^{[1
]}

Alieksieieva, Diana O. ^{[1
]}

Zabolotna, Yuliana ^{[7
]}

Klimchuk, Olga ^{[7
]}

Horvath, Dragos ^{[7
]}

Marcou, Gilles ^{[7
]}

Ryabukhin, Sergey, V ^{[1
,4
,5
]}

Varnek, Alexandre ^{[7
]}

机构：

[1] Enamine Ltd, 78 Chervonotkatska St, UA-02660 Kiev, Ukraine

[2] Natl Acad Sci Ukraine, Inst Food Biotechnol & Genom, 2a Osipovskogo St, UA-04123 Kiev, Ukraine

[3] Chemspace LLC, 85 Chervonotkatska St, UA-02094 Kiev, Ukraine

[4] Taras Shevchenko Natl Univ Kyiv, Educ & Sci Inst High Technol, 60 Volodymyrska St, UA-01033 Kiev, Ukraine

[5] Natl Acad Sci Ukraine, Inst Organ Chem, 5 Murmanska St, UA-03028 Kiev, Ukraine

[6] Natl Acad Sci Ukraine, Palladin Inst Biochem, 9 Leontovitcha St, UA-01054 Kiev, Ukraine

[7] Univ Strasbourg, Lab Chemoinformat, 4 Rue B Pascal, F-67081 Strasbourg, France

来源：

MOLECULES | 2022年 / 27卷 / 17期

基金：

新加坡国家研究基金会;

关键词：

QSAR modeling; molecular docking; Neprilysin; angiotensin-converting enzyme; selective ACE2 enzyme binding; blood-brain barrier penetration; enzymology inhibition assay adjustment; in vitro studies; DOCKING; ICM; ARCHITECTURE; INHIBITORS; PLATFORM; DESIGN; POTENT; DOMAIN;

D O I：

10.3390/molecules27175400

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

New models for ACE2 receptor binding, based on QSAR and docking algorithms were developed, using XRD structural data and ChEMBL 26 database hits as training sets. The selectivity of the potential ACE2-binding ligands towards Neprilysin (NEP) and ACE was evaluated. The Enamine screening collection (3.2 million compounds) was virtually screened according to the above models, in order to find possible ACE2-chemical probes, useful for the study of SARS-CoV2-induced neurological disorders. An enzymology inhibition assay for ACE2 was optimized, and the combined diversified set of predicted selective ACE2-binding molecules from QSAR modeling, docking, and ultrafast docking was screened in vitro. The in vitro hits included two novel chemotypes suitable for further optimization.

引用

页数：18

共 50 条

[31] Binding affinity improvement analysis of multiple-mutant Omicron on 2019-nCov to human ACE2 by in silico predictions
Li, Bo
Guo, Jindan
Hu, Wenxiang
Chen, Yubao
[J]. JOURNAL OF MOLECULAR MODELING, 2023, 29 (05)
[32] In Silico Prediction of New Mutations That Can Improve the Binding Abilities Between 2019-nCoV Coronavirus and Human ACE2
Fang, Senbiao
Zheng, Ruoqian
Lei, Chuqi
Wang, Jianxin
Zhou, Renyi
Li, Min
[J]. IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2022, 19 (03) : 1694 - 1702
[33] Phytochemical Screening of Adathodai Kudineer A Siddha Herbal concoction and Evaluation of its binding affinity with SARS-CoV-2 Spike Protein and ACE2 Receptor Spike protein Complex through Molecular Docking in silico approach
Christian, G. J.
Meenakumari, R.
Rajamaheswari, K.
Sekaran, Priyanka
Gajalakshmi, G.
Anand, T.
[J]. INTERNATIONAL JOURNAL OF AYURVEDIC MEDICINE, 2021, 12 (02) : 366 - 374
[34] In Silico, In Vitro and In Cellulo Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion
Lapaillerie, Delphine
Charlier, Cathy
Fernandes, Henrique S.
Sousa, Sergio F.
Lesbats, Paul
Weigel, Pierre
Favereaux, Alexandre
Guyonnet-Duperat, Veronique
Parissi, Vincent
[J]. VIRUSES-BASEL, 2021, 13 (03):
[35] Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
Kemenesi, Gabor
Toth, Gabor Endre
Bajusz, David
Keseru, Gyorgy M.
Terhes, Gabriella
Burian, Katalin
Zeghbib, Safia
Somogyi, Balazs A.
Jakab, Ferenc
[J]. GENES, 2021, 12 (02) : 1 - 10
[36] Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
Omotuyi, Olaposi
Olatunji, Olusina M.
Nash, Oyekanmi
Oyinloye, Babatunji
Soremekun, Opeyemi
Ijagbuji, Ayodeji
Fatumo, Segun
[J]. MICROBIAL PATHOGENESIS, 2023, 176
[37] Pharmacokinetic and Toxicological Evaluation of a Zinc Gluconate-Based Chemical Sterilant Using In Vitro and In Silico Approaches
Araujo-Lima, Carlos F.
Nunes, Rafael J. M.
Carpes, Raphael M.
Aiub, Claudia A. F.
Felzenszwalb, Israel
[J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[38] Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
Zareei, Sara
Pourmand, Saeed
Amanlou, Massoud
[J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
[39] In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells
Ayyamperumal, Selvaraj
Jade, Dhananjay
Tallapaneni, Vyshnavi
Chandrasekar, M. J. N.
Nanjan, M. J.
[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21): : 11383 - 11394
[40] In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding
Bate, Neil
Savva, Christos G.
Moody, Peter C. E.
Brown, Edward A.
Evans, Sian E.
Ball, Jonathan K.
Schwabe, John W. R.
Sale, Julian E.
Brindle, Nicholas P. J.
[J]. PLOS PATHOGENS, 2022, 18 (07)

← 1 2 3 4 5 →